Socialiya - Entertainment. Knowledge. Community.
Combination of pancreatic cancer drugs from Tango, Revolution leads to high response rate

The two drugs, vopimetostat from Tango Therapeutics and daraxonrasib from Revolution Medicines, will...

BUSINESS NEWS June 08, 2026

Combination of pancreatic cancer drugs from Tango, Revolution leads to high response rate

The two drugs, vopimetostat from Tango Therapeutics and daraxonrasib from Revolution Medicines, will now be tested in a Phase 3 trial.

2 views 0 likes 0 comments
Share:
The two drugs, vopimetostat from Tango Therapeutics and daraxonrasib from Revolution Medicines, will now be tested in a Phase 3 trial.

Author: statnews.com

Read Original Article

Related News

Advertisement
socialiya
Advertisement

Top Categories

Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya